[Fetal valproate syndrome].
Sonoda
T
T
Department of Pediatrics, Miyazaki Medical College.
D000014:Abnormalities, Drug-Induced / Q000503:physiopathology; D000015:Abnormalities, Multiple / Q000139:chemically induced* / Q000503:physiopathology; D000927:Anticonvulsants / Q000009:adverse effects*; D003937:Diagnosis, Differential; D005260:Female; D005315:Fetal Diseases / Q000139:chemically induced*; D005333:Fetus / Q000002:abnormalities*; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D011379:Prognosis; D013577:Syndrome; D014635:Valproic Acid / Q000009:adverse effects*
D000927:Anticonvulsants; D014635:Valproic Acid